Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer.
O'Neil BH, Raftery L, Calvo BF, Chakravarthy AB, Ivanova A, Myers MO, Kim HJ, Chan E, Wise PE, Caskey LS, Bernard SA, Sanoff HK, Goldberg RM, Tepper JE. O'Neil BH, et al. Among authors: bernard sa. Clin Colorectal Cancer. 2010 Apr;9(2):119-25. doi: 10.3816/CCC.2010.n.017. Clin Colorectal Cancer. 2010. PMID: 20378507 Free PMC article. Clinical Trial.
A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma.
Raftery L, Tepper JE, Goldberg RM, Blackstock AW, Aklilu M, Bernard SA, Ivanova A, Davies JM, O'Neil BH. Raftery L, et al. Among authors: bernard sa. Am J Clin Oncol. 2013 Jun;36(3):250-3. doi: 10.1097/COC.0b013e3182467f22. Am J Clin Oncol. 2013. PMID: 22547007 Free PMC article. Clinical Trial.
Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.
O'Neil BH, Funkhouser WK, Calvo BF, Meyers MO, Kim HJ, Goldberg RM, Bernard SA, Caskey L, Deal AM, Wright F, Baldwin AS, Tepper JE. O'Neil BH, et al. Among authors: bernard sa. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):705-11. doi: 10.1016/j.ijrobp.2010.02.063. Epub 2010 Jul 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 20630669 Free PMC article.
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.
Ramanathan RK, Bjarnason GA, Bernard SA, Desimone P, Braich T, Evars JP, Hrushesky WJ, Jolivet J. Ramanathan RK, et al. Among authors: bernard sa. Clin Colorectal Cancer. 2008 Mar;7(2):134-9. doi: 10.3816/ccc.2008.n.018. Clin Colorectal Cancer. 2008. PMID: 18501073 Clinical Trial.
140 results